Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP899433.RAEkkKzxARCDm1qF6J_0ptkZPczKpeDbXUVDleE8rjO0k130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP899433.RAEkkKzxARCDm1qF6J_0ptkZPczKpeDbXUVDleE8rjO0k130_assertion type Assertion NP899433.RAEkkKzxARCDm1qF6J_0ptkZPczKpeDbXUVDleE8rjO0k130_head.
- NP899433.RAEkkKzxARCDm1qF6J_0ptkZPczKpeDbXUVDleE8rjO0k130_assertion description "[Imatinib is effective in patients with increased mast cells and eosinophils associated with FIP1L1/PDGFRA+ (e.g., myeloid neoplasm with eosinophilia and rearrangement of PDGFRA) or rare patients with SM associated with KIT mutations outside of exon 17.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP899433.RAEkkKzxARCDm1qF6J_0ptkZPczKpeDbXUVDleE8rjO0k130_provenance.
- NP899433.RAEkkKzxARCDm1qF6J_0ptkZPczKpeDbXUVDleE8rjO0k130_assertion evidence source_evidence_literature NP899433.RAEkkKzxARCDm1qF6J_0ptkZPczKpeDbXUVDleE8rjO0k130_provenance.
- NP899433.RAEkkKzxARCDm1qF6J_0ptkZPczKpeDbXUVDleE8rjO0k130_assertion SIO_000772 21641642 NP899433.RAEkkKzxARCDm1qF6J_0ptkZPczKpeDbXUVDleE8rjO0k130_provenance.
- NP899433.RAEkkKzxARCDm1qF6J_0ptkZPczKpeDbXUVDleE8rjO0k130_assertion wasDerivedFrom befree-2016 NP899433.RAEkkKzxARCDm1qF6J_0ptkZPczKpeDbXUVDleE8rjO0k130_provenance.
- NP899433.RAEkkKzxARCDm1qF6J_0ptkZPczKpeDbXUVDleE8rjO0k130_assertion wasGeneratedBy ECO_0000203 NP899433.RAEkkKzxARCDm1qF6J_0ptkZPczKpeDbXUVDleE8rjO0k130_provenance.